Long-term efficacy and safety results: Can enzalutamide challenge the dogma of androgen deprivation therapy in Hormone-naïve prostate cancer?

Laurence Albiges, Yohann Loriot, Christophe Massard, Karim Fizazi

    Research output: Contribution to journalEditorial

    Original languageEnglish
    Pages (from-to)802-804
    Number of pages3
    JournalEuropean Urology
    Volume68
    Issue number5
    DOIs
    Publication statusPublished - 1 Nov 2015

    Cite this